Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CROSS_SEEDING: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Target | Relation | Type | Str |
|---|---|---|---|
| multiple_system_atrophy | associated_with | disease | 0.60 |
| neurodegeneration | causes | disease | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| HSPG2 | platform_for | gene | 0.75 |
| prohibitin-2 | associated_with | protein | 0.60 |
| beta_sheet_structure | promotes | pathway | 0.60 |
| protein_misfolding | causes | biological_process | 0.60 |
| transglutaminase-2 | promotes | protein | 0.60 |
| glycosaminoglycan | promotes | pathway | 0.60 |
| microglia | inhibits | cell_type | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Cross-Seeding Prevention Strategy | 0.689 | neurodegeneration | RNA binding protein dysregulation across |
| Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro | 0.642 | neurodegeneration | What are the mechanisms by which gut mic |
| Tau Cross-Seeding and Interaction | 0.610 | neurodegeneration | What mechanisms underlie TDP-43's contri |
| HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor | 0.544 | neurodegeneration | Protein aggregation cross-seeding across |
| Cross-Seeding: Gut Microbiome-Derived Bacterial Curli and Fu | 0.540 | neurodegeneration | How does gut microbiome dysbiosis contri |
| G3BP1-TDP-43 Cross-Seeding Drives Co-Aggregation That Prion- | 0.490 | neurodegeneration | How do disease-associated mutations in G |
| Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption | 0.469 | neurodegeneration | Protein aggregation cross-seeding across |
| RNA-Binding Competition Therapy for TDP-43 Cross-Seeding | 0.465 | neurodegeneration | Protein aggregation cross-seeding across |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.639
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Nation-wide NGS-based genetic screening of LGMD patients in US | exploratory | Limb-girdle muscular dystrophy | 0.950 | 0.00 | Human patients | proposed | N/A |
| TDP-43 mutant mouse model cGAS/STING pathway analysis | validation | amyotrophic lateral sclerosis | 0.900 | 0.00 | TDP-43 mutant mice | proposed | N/A |
| TDP-43 mitochondrial invasion and DNA release via mPTP | exploratory | amyotrophic lateral sclerosis | 0.900 | 0.00 | cultured cells | proposed | N/A |
| TDP-43 mitochondrial invasion and mtDNA release in iPSC motor neurons | exploratory | Amyotrophic Lateral Sclerosis | 0.900 | 0.00 | iPSC-derived motor neurons | proposed | N/A |
| cGAS/STING pathway validation in TDP-43 mutant mice | validation | Amyotrophic Lateral Sclerosis | 0.850 | 0.00 | TDP-43 mutant mice | proposed | N/A |
| cGAMP biomarker analysis in ALS patient spinal cord samples | exploratory | Amyotrophic Lateral Sclerosis | 0.800 | 0.00 | Human ALS patient spinal cord | proposed | N/A |
| TDP-43 pathology prevalence and distribution in AD cases | exploratory | Alzheimer's disease | 0.800 | 0.00 | human postmortem brain tissue | proposed | N/A |
| Cognitive impact of TDP-43 pathology in AD patients | clinical | Alzheimer's disease | 0.700 | 0.00 | human patients | completed | N/A |
| Proposed experiment from debate on TDP-43 undergoes liquid-liquid phas | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $80,000 |
| s:** - Single-cell RNA-seq to measure editing efficiency across differ | falsification | ALS | 0.400 | 0.50 | cell_line | proposed | $150,000 |
| Alpha-Synuclein SAA Kinetics Study — Biological Staging Backbone for P | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Autophagy and ALS: mechanistic insights and therapeutic implications. [PMID:34057020] | Chua JP, De Calbiac H, Kabashi E, Barmad | Autophagy | 2022 | 2 |
| TDP-43 Pathology in Alzheimer's Disease. [PMID:34930382] | Meneses A, Koga S, O'Leary J, Dickson DW | Mol Neurodegener | 2021 | 2 |
| Organelle-specific autophagy in inflammatory diseases: a potential therapeutic t [PMID:32048886] | Yao RQ, Ren C, Xia ZF, Yao YM | Autophagy | 2021 | 2 |
| Protein transmission in neurodegenerative disease. [PMID:32203399] | Peng C, Trojanowski JQ, Lee VM | Nat Rev Neurol | 2020 | 2 |
| TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS [PMID:33031745] | Yu CH, Davidson S, Harapas CR, Hilton JB | Cell | 2020 | 2 |
| N protein of PEDV plays chess game with host proteins by selective autophagy. [PMID:36861818] | Zhai X, Kong N, Zhang Y, Song Y, Qin W, | Autophagy | 2023 | 1 |
| ALS-related proteinopathies: From TDP-43 to mitochondrial proteinopathies. [PMID:41570741] | Genin EC, Paquis-Flucklinger V | Current opinion in neurobiolog | 2026 | 0 |
| Role of Alpha-Synuclein in Frontotemporal Dementia: Narrative Review. [PMID:41827903] | Bougea A | Cells | 2026 | 0 |
| Macrophage TRIM21 Inhibition Ameliorates Murine Acute Pancreatitis via PHB2-Medi [PMID:41572443] | Xu Y, Sun Y, Zhou X, Song K, Yin C et al | Adv Sci (Weinh) | 2026 | 0 |
| Src-mediated PHB2 phosphorylation disrupts mitochondrial cristae through cardiol [PMID:41666677] | Shao Z, Yang X, Wang B, Wang X, Zhao D e | Redox Biol | 2026 | 0 |
| Refolding-assisted purification of native full-length TDP-43 compatible with BSL [PMID:41692368] | Dehury S, Tiwari S, Los Rios P | Methods | 2026 | 0 |
| Small heat shock proteins HspB1 and HspB5 differentially alter the condensation [PMID:41854301] | Walker TB, Trowbridge JW, McMahon S, Mar | Protein Sci | 2026 | 0 |
| Structural and Mechanistic Heterogeneity of the Phase Separation and Aggregation [PMID:41871974] | Doke AA, Kirmire MS, Jha A, Jha SK | ACS Chem Neurosci | 2026 | 0 |
| Mitochondria-Related Pathogenic Genes in Paediatric Asthma: A Multi-Omics Mendel [PMID:41896191] | Zhang B, Li Y, Ding B, Li X, Lu Y | J Cell Mol Med | 2026 | 0 |
| Interaction of mtROS-Immune-Inflammatory Vicious Cycle Activation in Sepsis-Indu [PMID:41905969] | Wang Y, Yuan Q | Clin Exp Pharmacol Physiol | 2026 | 0 |
| The Genetics of TDP-43 Type C Neurodegeneration: A Whole-Genome Sequencing Study [PMID:41883703] | Nassan M, Ayala I, Sloan J, Bonfitto A, | Neurology. Genetics | 2026 | 0 |
| Computational examination of magainin-I-KL mediated disruption of E. coli biofil [PMID:41724836] | Vinutha AS, Akshay S, Sree Agash SG, Cha | Archives of microbiology | 2026 | 0 |
| Antisense oligonucleotide targeting TARDBP-EGFR splicing axis inhibits progressi [PMID:41540015] | Ni N, Wang M, Yuan Z, Zhang L, Cai J, Du | International journal of oral | 2026 | 0 |
| The cytoplasmic protein YedX is a potent inhibitor of CsgA amyloid assembly in E [PMID:41581877] | Gurnani B, Jain N | The Journal of biological chem | 2026 | 0 |
| DNAJB6: A guardian against neurodegeneration. [PMID:40536953] | Hentze J, Gelman A, Brudek T, Hansen C | Neural regeneration research | 2026 | 0 |
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning CROSS_SEEDING in their description or question text
Score: 0.490 · neurodegeneration · 2026-04-22
## Mechanistic Overview G3BP1-TDP-43 Cross-Seeding Drives Co-Aggregation That Prion-Spreads Across Neural Circuits start
Score: 0.469 · neurodegeneration · 2026-04-02
Prohibitin-2 serves as a convergent mitochondrial platform where tau, α-synuclein, and TDP-43 interact and undergo confo
Score: 0.465 · neurodegeneration · 2026-04-02
Synthetic RNA aptamers designed to competitively bind TDP-43's RNA recognition motifs could prevent its interaction with